SynthesisBritish journal of haematology2010

Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia.

Fabio P S Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.